Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 461

1.

Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.

Wysoczynski M, Pathan A, Moore JB 4th, Farid T, Kim J, Nasr M, Kang Y, Li H, Bolli R.

Stem Cell Rev. 2019 May 17. doi: 10.1007/s12015-019-09891-6. [Epub ahead of print]

PMID:
31102187
2.

William Harvey and the Discovery of the Circulation of the Blood.

Bolli R.

Circ Res. 2019 May 10;124(10):1428-1429. doi: 10.1161/CIRCRESAHA.119.314978. No abstract available.

PMID:
31071006
3.

Transcription Factor STAT3 Serves as a Negative Regulator Controlling IgE Class Switching in Mice.

Dascani P, Ding C, Kong X, Tieri D, Hu X, Zhang HG, Kitamura D, Bolli R, Rouchka EC, Yan J.

Immunohorizons. 2018 Dec 5;2(11):349-362. doi: 10.4049/immunohorizons.1800069.

PMID:
31026806
4.

William Harvey and the Discovery of the Circulation of the Blood.

Bolli R.

Circ Res. 2019 Apr 26;124(9):1300-1302. doi: 10.1161/CIRCRESAHA.119.314977. No abstract available.

PMID:
31021729
5.

Human Embryonic Stem Cell-Derived Cardiomyocytes.

Bolli R, Wysoczynski M.

Circ Res. 2019 Apr 12;124(8):1157-1159. doi: 10.1161/CIRCRESAHA.119.314869. No abstract available.

PMID:
30973816
6.

William Harvey and the Discovery of the Circulation of the Blood.

Bolli R.

Circ Res. 2019 Apr 12;124(8):1169-1171. doi: 10.1161/CIRCRESAHA.119.314976. No abstract available.

PMID:
30973803
7.

Correction: The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-related kinase (ERK)/NRF2 signaling pathway and cytokine release.

Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, Rokosh G, Bhatnagar A, Bolli R.

J Biol Chem. 2019 Mar 22;294(12):4725-4727. doi: 10.1074/jbc.AAC119.008182. No abstract available.

8.

Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine.

Grigorian Shamagian L, Madonna R, Taylor D, Climent AM, Prosper F, Bras-Rosario L, Bayes-Genis A, Ferdinandy P, Fernández-Avilés F, Izpisua Belmonte JC, Fuster V, Bolli R.

Circ Res. 2019 Mar 15;124(6):938-951. doi: 10.1161/CIRCRESAHA.118.313795.

PMID:
30870121
9.

Potential Strategies for Clinical Translation of Repeated Cell Therapy.

Vrtovec B, Bolli R.

Circ Res. 2019 Mar;124(5):690-692. doi: 10.1161/CIRCRESAHA.118.314653. No abstract available.

PMID:
30817255
10.

TRPA1 channel contributes to myocardial ischemia-reperfusion injury.

Conklin DJ, Guo Y, Nystoriak MA, Jagatheesan G, Obal D, Kilfoil PJ, Hoetker JD, Guo L, Bolli R, Bhatnagar A.

Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H889-H899. doi: 10.1152/ajpheart.00106.2018. Epub 2019 Feb 8.

PMID:
30735434
11.

Paul Simpson and Scientific Rigor.

Bolli R.

Circ Res. 2019 Jan 18;124(2):194. doi: 10.1161/CIRCRESAHA.118.314621. No abstract available.

PMID:
30653441
12.

Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.

Berry JL, Zhu W, Tang YL, Krishnamurthy P, Ge Y, Cooke JP, Chen Y, Garry DJ, Yang HT, Rajasekaran NS, Koch WJ, Li S, Domae K, Qin G, Cheng K, Kamp TJ, Ye L, Hu S, Ogle BM, Rogers JM, Abel ED, Davis ME, Prabhu SD, Liao R, Pu WT, Wang Y, Ping P, Bursac N, Vunjak-Novakovic G, Wu JC, Bolli R, Menasché P, Zhang J.

Circ Res. 2019 Jan 4;124(1):161-169. doi: 10.1161/CIRCRESAHA.118.314216.

PMID:
30605412
13.

Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.

Moore JB 4th, Tang XL, Zhao J, Fischer AG, Wu WJ, Uchida S, Gumpert AM, Stowers H, Wysoczynski M, Bolli R.

Basic Res Cardiol. 2018 Nov 16;114(1):3. doi: 10.1007/s00395-018-0710-1.

PMID:
30446837
14.

The Impact Factor of Circulation Research Reaches Another New High.

Bolli R.

Circ Res. 2018 Aug 17;123(5):510-511. doi: 10.1161/CIRCRESAHA.118.313763. No abstract available.

PMID:
30355142
15.

Introduction to Cardiovascular Aging Compendium.

Marian AJ, Bhatnagar A, Bolli R, Izpisua Belmonte JC.

Circ Res. 2018 Sep 14;123(7):737-739. doi: 10.1161/CIRCRESAHA.118.313940. No abstract available.

PMID:
30355084
16.

Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Mehra P, Guo Y, Nong Y, Lorkiewicz P, Nasr M, Li Q, Muthusamy S, Bradley JA, Bhatnagar A, Wysoczynski M, Bolli R, Hill BG.

Basic Res Cardiol. 2018 Oct 23;113(6):46. doi: 10.1007/s00395-018-0703-0.

17.

Effect of Molecular Weight on Sonoporation-Mediated Uptake in Human Cells.

Bhutto DF, Murphy EM, Priddy MC, Centner CC, Moore Iv JB, Bolli R, Kopechek JA.

Ultrasound Med Biol. 2018 Dec;44(12):2662-2672. doi: 10.1016/j.ultrasmedbio.2018.08.008. Epub 2018 Sep 29.

PMID:
30274682
18.

Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions.

Banerjee MN, Bolli R, Hare JM.

Circ Res. 2018 Jul 6;123(2):266-287. doi: 10.1161/CIRCRESAHA.118.311217.

PMID:
29976692
19.

New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.

Wysoczynski M, Khan A, Bolli R.

Circ Res. 2018 Jul 6;123(2):138-158. doi: 10.1161/CIRCRESAHA.118.313251.

PMID:
29976684
20.

Introduction to a Compendium on Regenerative Cardiology.

Bolli R, Hare J.

Circ Res. 2018 Jul 6;123(2):129-131. doi: 10.1161/CIRCRESAHA.118.313576. No abstract available.

PMID:
29976682
21.

Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.

Bolli R, Hare JM, Henry TD, Lenneman CG, March KL, Miller K, Pepine CJ, Perin EC, Traverse JH, Willerson JT, Yang PC, Gee AP, Lima JA, Moyé L, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2018 Jul;201:54-62. doi: 10.1016/j.ahj.2018.02.009. Epub 2018 Apr 4.

PMID:
29910056
22.

Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).

Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, Yang PC, Henry TD, Traverse JH, Mitrani RD, Khan A, Hernandez-Schulman I, Taylor DA, DiFede DL, Lima JAC, Chugh A, Loughran J, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Moyé L, Ebert RF, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2018 Jun 8;122(12):1703-1715. doi: 10.1161/CIRCRESAHA.118.312978. Epub 2018 Apr 27.

PMID:
29703749
23.

A Call to Make the Human Dimension of Science a Core Component of Scientific Journals.

Bolli R.

Circ Res. 2018 Mar 30;122(7):907-910. doi: 10.1161/CIRCRESAHA.118.312947. No abstract available.

PMID:
29599270
24.

Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2018 Mar 6;8(1):4257. doi: 10.1038/s41598-018-22121-2.

25.

Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose.

Tang XL, Nakamura S, Li Q, Wysoczynski M, Gumpert AM, Wu WJ, Hunt G, Stowers H, Ou Q, Bolli R.

J Am Heart Assoc. 2018 Feb 13;7(4). pii: e007400. doi: 10.1161/JAHA.117.007400.

26.

Circulation Research 2017 Best Manuscript Award Winners.

Bolli R.

Circ Res. 2018 Feb 2;122(3):396-398. doi: 10.1161/CIRCRESAHA.118.312681. No abstract available.

PMID:
29420207
27.

Guidelines for experimental models of myocardial ischemia and infarction.

Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G.

Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H812-H838. doi: 10.1152/ajpheart.00335.2017. Epub 2018 Jan 12.

28.

Translational Research in Cardiovascular Repair: A Call for a Paradigm Shift.

Chamuleau SAJ, van der Naald M, Climent AM, Kraaijeveld AO, Wever KE, Duncker DJ, Fernández-Avilés F, Bolli R; Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Group.

Circ Res. 2018 Jan 19;122(2):310-318. doi: 10.1161/CIRCRESAHA.117.311565. Review.

PMID:
29348252
29.

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group.

Circ Res. 2018 Jan 19;122(2):199-201. doi: 10.1161/CIRCRESAHA.117.312099. No abstract available.

PMID:
29348246
30.

Cell therapy for heart disease: current status and future directions.

Kahlon A, Vaidya G, Bolli R.

Minerva Cardioangiol. 2018 Jun;66(3):273-291. doi: 10.23736/S0026-4725.18.04596-6. Epub 2018 Jan 10. Review.

PMID:
29327894
31.

Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.

Uchida S, Bolli R.

Antioxid Redox Signal. 2018 Sep 20;29(9):832-845. doi: 10.1089/ars.2017.7262. Epub 2017 Sep 28.

PMID:
28847161
32.

New Initiatives to Improve the Rigor and Reproducibility of Articles Published in Circulation Research.

Bolli R.

Circ Res. 2017 Aug 18;121(5):472-479. doi: 10.1161/CIRCRESAHA.117.311678. No abstract available.

PMID:
28819032
33.

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.

Yanamandala M, Zhu W, Garry DJ, Kamp TJ, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu SD, Dorn GW 2nd, Bolli R, Kitsis RN, Zhang J.

J Am Coll Cardiol. 2017 Aug 8;70(6):766-775. doi: 10.1016/j.jacc.2017.06.012. Review.

34.

The Impact Factor of Circulation Research Reaches a New High.

Bolli R.

Circ Res. 2017 Jul 21;121(3):199. doi: 10.1161/CIRCRESAHA.117.311564. No abstract available.

PMID:
28729447
35.

Cardiomyocyte Regeneration: A Consensus Statement.

Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisén J, Giacca M, Hare JM, Houser S, Lee RT, Marbán E, Martin JF, Molkentin JD, Murry CE, Riley PR, Ruiz-Lozano P, Sadek HA, Sussman MA, Hill JA.

Circulation. 2017 Aug 15;136(7):680-686. doi: 10.1161/CIRCULATIONAHA.117.029343. Epub 2017 Jul 6. Review. No abstract available.

36.

Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion.

Moore JB 4th, Zhao J, Fischer AG, Keith MCL, Hagan D, Wysoczynski M, Bolli R.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e006183. doi: 10.1161/JAHA.117.006183.

37.

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2017 Jun 30;7(1):4419. doi: 10.1038/s41598-017-04801-7. Erratum in: Sci Rep. 2018 Mar 6;8(1):4257.

38.

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.

Youssef AA, Ross EG, Bolli R, Pepine CJ, Leeper NJ, Yang PC.

JACC Basic Transl Sci. 2016 Oct;1(6):510-523. doi: 10.1016/j.jacbts.2016.06.010.

39.

Global position paper on cardiovascular regenerative medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee.

Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248. No abstract available. Erratum in: Eur Heart J. 2018 May 14;39(19):1723.

40.

Neurocognitive Risk With PCSK9 Inhibitors: Need for More Robust Evidence.

Khan AR, Riaz H, Farid T, Bolli R.

J Am Coll Cardiol. 2017 May 16;69(19):2468-2469. doi: 10.1016/j.jacc.2017.02.063. No abstract available.

41.

Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.

Shahrivari M, Wise E, Resende M, Shuster JJ, Zhang J, Bolli R, Cooke JP, Hare JM, Henry TD, Khan A, Taylor DA, Traverse JH, Yang PC, Pepine CJ, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2017 Jun 9;120(12):1947-1957. doi: 10.1161/CIRCRESAHA.116.309947. Epub 2017 May 10.

42.

Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence.

Wysoczynski M, Guo Y, Moore JB 4th, Muthusamy S, Li Q, Nasr M, Li H, Nong Y, Wu W, Tomlin AA, Zhu X, Hunt G, Gumpert AM, Book MJ, Khan A, Tang XL, Bolli R.

J Am Coll Cardiol. 2017 Apr 11;69(14):1824-1838. doi: 10.1016/j.jacc.2017.01.048.

43.

Stem cells: Cell therapy for cardiac repair: what is needed to move forward?

Bolli R, Ghafghazi S.

Nat Rev Cardiol. 2017 May;14(5):257-258. doi: 10.1038/nrcardio.2017.38. Epub 2017 Mar 31. No abstract available.

PMID:
28361979
44.

Trainees in the Spotlight: Yet Another Addition to Our Portfolio.

Bolli R.

Circ Res. 2017 Mar 31;120(7):1048-1049. doi: 10.1161/CIRCRESAHA.117.310936. No abstract available.

PMID:
28360337
45.

Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells.

Al-Maqtari T, Hong KU, Vajravelu BN, Moktar A, Cao P, Moore JB 4th, Bolli R.

PLoS One. 2017 Mar 29;12(3):e0174242. doi: 10.1371/journal.pone.0174242. eCollection 2017.

46.

The 10 Most Read Articles Published in Circulation Research in 2016.

Bolli R; Editors.

Circ Res. 2017 Mar 3;120(5):767-771. doi: 10.1161/CIRCRESAHA.117.310755. No abstract available.

PMID:
28254799
47.

Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.

Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert AM, Nasr M, Muthusamy S, Li H, Book M, Khan A, Hong KU, Li Q, Bolli R.

Basic Res Cardiol. 2017 Mar;112(2):18. doi: 10.1007/s00395-017-0606-5. Epub 2017 Feb 16.

48.

Announcing the "Meet the First Author" Page.

Bolli R.

Circ Res. 2017 Feb 17;120(4):595. doi: 10.1161/CIRCRESAHA.117.310704. No abstract available.

PMID:
28209784
49.

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT; Cardiovascular Cell Therapy Research Network (CCTRN).

Circulation. 2017 Apr 11;135(15):1417-1428. doi: 10.1161/CIRCULATIONAHA.116.025707. Epub 2017 Feb 16.

50.

Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come.

Bolli R.

Circ Res. 2017 Mar 31;120(7):1072-1074. doi: 10.1161/CIRCRESAHA.117.310710. Epub 2017 Feb 8. No abstract available.

Supplemental Content

Support Center